文献速递肝胆胰外科围术期管理与 ERAS

腹腔镜胰腺剜除术:为保留实质能走多远?法国国家外科协会研究

Laparoscopic pancreatic enucleation: how far should we go for parenchyma preservation? A study by the French National Association of Surgery.
PubMed 文献 · Surg Endosc · 2025-01-13

该回顾性多中心队列研究纳入2010至2021年27个中心的200例微创胰腺剜除术(MIPE),评估肿瘤位置和中心经验对教科书结局(TBO)的影响。结果显示总体死亡率1.5%,头/钩突病变TBO率52%,胰颈73%,体/尾67%(p=0.09),头/钩突病变出血和胆漏更高。高容量中心适应症更广但TBO无显著差异。

要点

  • MIPE总体死亡率1.5%,头/钩突病变并发症更高。
  • 头/钩突病变TBO率52%,低于胰颈73%和体/尾67%。
  • 超重、术前活检和头/钩突位置与较低TBO独立相关。

核心结论

  • MIPE可行且死亡率1.5%,头/钩突病变并发症更高,但为避免胰十二指肠切除术仍可接受。
  • 高容量中心扩大MIPE适应症未增加并发症。

研究设计与样本

  • 回顾性全国多中心队列研究,纳入2010至2021年27个中心的200例MIPE。
  • 肿瘤位置分为头/钩突(n=65,33%)、胰颈(n=26,13%)和体/尾(n=109,55%),8%为机器人手术。
  • 中心按年均微创胰腺切除术量分为低量(<5/年)、中量(5-10/年)和高量(≥10/年)。

主要发现

  • 总体死亡率1.5%(n=3)。
  • 头/钩突病变更大(p=0.03),更常见BD-IPMN(p=0.04),手术时间更长(p=0.002)。
  • TBO率头/钩突52%、胰颈73%、体/尾67%(p=0.09),头/钩突病变术后胰腺切除出血(p=0.03)和胆漏(p=0.03)更高。
  • 多因素分析中,超重(OR 0.49)、术前活检(OR 0.41)和头/钩突病变(OR 0.34)与较低TBO独立相关。
  • 高容量中心囊性病变更多(p=0.002)、肿瘤更大(p=0.003)、3D使用更多(p=0.001)、头/钩突病变更多(p=0.04),但TBO无显著差异(p=0.45)。

关键数值与推荐

  • TBO定义为同时满足6项标准:无术后胰腺瘘(POPF)、无术后胰腺切除出血(PPH)、无胆漏、无再入院、无死亡、无严重并发症。

临床怎么用

  • MIPE可用于选定患者以保留胰腺实质,头/钩突病变需权衡更高并发症风险。
  • 高容量中心可扩大MIPE适应症而不增加并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pancreatic enucleation is indicated for selected patients and tumours with very low oncological risk to preserve a maximum of healthy pancreatic parenchyma. Minimally invasive pancreatic enucleation (MIPE) is increasingly performed. This study aims to assess the impact of tumor location and center experience on textbook outcomes (TBO) in patients undergoing MIPE. METHODS: Retrospective nationwide multicentric cohort study including MIPE performed between 2010 and 2021. Tumor localization was classified as head/uncus, neck or body/tail (results are presented in this order). Centers were classified according to a mean volume of MI pancreatectomies performed per year: lower (< 5/year), intermediate (5 to 10/year) and higher volume (≥ 10/year). TBO was defined as meeting all 6 criteria: no postoperative pancreatic fistula (POPF), no post-pancreatectomy haemorrhage (PPH), no bile leak, no readmission, no mortality, and no severe morbidity. RESULTS: 27 participating centers performed 200 MIPE located in head/uncus (n = 65, 33%), neck (n = 26, 13%) and body/tail (n = 109, 55%), 8% of them performed by robotic approach. Mortality reached 1.5% (n = 3). Head/uncus lesions were larger (p = 0.03), frequently BD-IPMN (p = 0.04), with significant longer operative time (p = 0.002). TBO achievement was high across all tumor locations (52 vs. 73 vs. 67%, p = 0.09) with higher PPH (p = 0.03) or bile leaks (p = 0.03) for head/uncus lesions. In multivariate analysis, overweight (OR 0.49), preoperative biopsy (OR 0.41) and head/uncus lesion (OR 0.34) were independently associated with lower TBO. No independent risk factor was found for POPF or severe morbidity. While expertise level influenced indications, with more cystic lesions (p = 0.002), larger tumors (p = 0.003), 3D use (p = 0.001), and head/uncus lesions (p = 0.04) in high volume centers, TBO was not significantly different (p = 0.45). CONCLUSIONS: MIPE is feasible with 1.5% mortality whatever its localization with higher morbidity for head/uncus lesions, justified by the will to avoid pancreaticoduodenectomy. High volume centers push the limits of MIPE without increasing morbidity.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Pastier C, De Ponthaud C, Nassar A, et al. Laparoscopic pancreatic enucleation: how far should we go for parenchyma preservation? A study by the French National Association of Surgery. Surg Endosc. 2025. PMID: 39806174. doi:10.1007/s00464-024-11453-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。